• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎(COVID-19)诊断临床决策支持:CORAL(COVID 风险计算器)的实施前后研究。

Coronavirus Disease 2019 (COVID-19) Diagnostic Clinical Decision Support: A Pre-Post Implementation Study of CORAL (COvid Risk cALculator).

机构信息

Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.

Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.

出版信息

Clin Infect Dis. 2021 Dec 16;73(12):2248-2256. doi: 10.1093/cid/ciab111.

DOI:10.1093/cid/ciab111
PMID:33564833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7929052/
Abstract

BACKGROUND

Isolation of hospitalized persons under investigation (PUIs) for coronavirus disease 2019 (COVID-19) reduces nosocomial transmission risk. Efficient evaluation of PUIs is needed to preserve scarce healthcare resources. We describe the development, implementation, and outcomes of an inpatient diagnostic algorithm and clinical decision support system (CDSS) to evaluate PUIs.

METHODS

We conducted a pre-post study of CORAL (COvid Risk cALculator), a CDSS that guides frontline clinicians through a risk-stratified COVID-19 diagnostic workup, removes transmission-based precautions when workup is complete and negative, and triages complex cases to infectious diseases (ID) physician review. Before CORAL, ID physicians reviewed all PUI records to guide workup and precautions. After CORAL, frontline clinicians evaluated PUIs directly using CORAL. We compared pre- and post-CORAL frequency of repeated severe acute respiratory syndrome coronavirus 2 nucleic acid amplification tests (NAATs), time from NAAT result to PUI status discontinuation, total duration of PUI status, and ID physician work hours, using linear and logistic regression, adjusted for COVID-19 incidence.

RESULTS

Fewer PUIs underwent repeated testing after an initial negative NAAT after CORAL than before CORAL (54% vs 67%, respectively; adjusted odd ratio, 0.53 [95% confidence interval, .44-.63]; P < .01). CORAL significantly reduced average time to PUI status discontinuation (adjusted difference [standard error], -7.4 [0.8] hours per patient), total duration of PUI status (-19.5 [1.9] hours per patient), and average ID physician work-hours (-57.4 [2.0] hours per day) (all P < .01). No patients had a positive NAAT result within 7 days after discontinuation of precautions via CORAL.

CONCLUSIONS

CORAL is an efficient and effective CDSS to guide frontline clinicians through the diagnostic evaluation of PUIs and safe discontinuation of precautions.

摘要

背景

对 2019 年冠状病毒病(COVID-19)下住院的疑似患者(PUIs)进行隔离可降低医院内传播的风险。需要高效地评估 PUIs,以保护有限的医疗资源。我们描述了一种住院患者诊断算法和临床决策支持系统(CDSS)的开发、实施和结果,以评估 PUIs。

方法

我们进行了 CORAL(COvid Risk cALculator)的前后研究,这是一种 CDSS,它通过风险分层 COVID-19 诊断工作流程指导一线临床医生,在工作流程完成且结果为阴性时消除基于传播的预防措施,并将复杂病例分诊给传染病(ID)医生进行审查。在 CORAL 之前,ID 医生审查所有 PUI 记录以指导工作流程和预防措施。在 CORAL 之后,一线临床医生直接使用 CORAL 评估 PUIs。我们使用线性和逻辑回归比较了 CORAL 前后重复严重急性呼吸综合征冠状病毒 2 核酸扩增试验(NAAT)的频率、从 NAAT 结果到 PUI 状态终止的时间、PUI 状态的总持续时间和 ID 医生的工作时间,调整了 COVID-19 的发病率。

结果

与 CORAL 之前相比,CORAL 后首次阴性 NAAT 后接受重复检测的 PUI 减少(分别为 54%和 67%;调整后的比值比,0.53[95%置信区间,0.44-0.63];P<0.01)。CORAL 显著缩短了 PUI 状态终止的平均时间(调整后的差异[标准误差],-7.4[0.8]小时/患者)、PUI 状态的总持续时间(-19.5[1.9]小时/患者)和 ID 医生的平均工作时间(-57.4[2.0]小时/天)(均 P<0.01)。没有患者在通过 CORAL 停止预防措施后 7 天内出现阳性 NAAT 结果。

结论

CORAL 是一种高效、有效的 CDSS,可指导一线临床医生对 PUIs 进行诊断评估,并安全地停止预防措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e0b/8677567/dc6526e9e5cb/ciab111f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e0b/8677567/5961d6b28612/ciab111f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e0b/8677567/04ae12d2d84c/ciab111f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e0b/8677567/dc6526e9e5cb/ciab111f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e0b/8677567/5961d6b28612/ciab111f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e0b/8677567/04ae12d2d84c/ciab111f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e0b/8677567/dc6526e9e5cb/ciab111f0003.jpg

相似文献

1
Coronavirus Disease 2019 (COVID-19) Diagnostic Clinical Decision Support: A Pre-Post Implementation Study of CORAL (COvid Risk cALculator).新型冠状病毒肺炎(COVID-19)诊断临床决策支持:CORAL(COVID 风险计算器)的实施前后研究。
Clin Infect Dis. 2021 Dec 16;73(12):2248-2256. doi: 10.1093/cid/ciab111.
2
Outcomes from an infectious disease physician-guided evaluation of hospitalized persons under investigation for coronavirus disease 2019 (COVID-19) at a large US academic medical center.美国一大学附属医院传染病专家对住院疑似 2019 冠状病毒病(COVID-19)患者的评估结果。
Infect Control Hosp Epidemiol. 2021 Mar;42(3):344-347. doi: 10.1017/ice.2020.434. Epub 2020 Aug 24.
3
Universal screening for SARS-CoV-2 infection: a rapid review.SARS-CoV-2 感染的普遍筛查:快速综述。
Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013718. doi: 10.1002/14651858.CD013718.
4
Demographic, clinical, and epidemiologic characteristics of persons under investigation for Coronavirus Disease 2019-United States, January 17-February 29, 2020.2019 年冠状病毒病(COVID-19)疑似病例的人口统计学、临床和流行病学特征——美国,2020 年 1 月 17 日-2 月 29 日。
PLoS One. 2021 Apr 15;16(4):e0249901. doi: 10.1371/journal.pone.0249901. eCollection 2021.
5
Nucleic acid amplification tests on respiratory samples for the diagnosis of coronavirus infections: a systematic review and meta-analysis.呼吸道样本核酸扩增检测用于冠状病毒感染诊断的系统评价和荟萃分析。
Clin Microbiol Infect. 2021 Mar;27(3):341-351. doi: 10.1016/j.cmi.2020.11.002. Epub 2020 Nov 11.
6
Implementation of close contact elicitation at the time of COVID-19 testing-Atlanta, GA, October-November 2020.实施 COVID-19 检测时的密切接触者排查——佐治亚州亚特兰大,2020 年 10 月至 11 月。
J Public Health (Oxf). 2022 Dec 1;44(4):877-880. doi: 10.1093/pubmed/fdab174.
7
Retrospective evaluation of clinical decision support for within-laboratory optimization of SARS-CoV-2 NAAT workflow.回顾性评估临床决策支持在 SARS-CoV-2 NAAT 工作流程室内优化中的应用。
J Clin Microbiol. 2024 Feb 14;62(2):e0078523. doi: 10.1128/jcm.00785-23. Epub 2023 Dec 22.
8
Sensitivity and Diagnostic Yield of the First SARS-CoV-2 Nucleic Acid Amplification Test Performed for Patients Presenting to the Hospital.首诊于医院患者的 SARS-CoV-2 核酸扩增检测的灵敏度和诊断收益。
JAMA Netw Open. 2022 Oct 3;5(10):e2236288. doi: 10.1001/jamanetworkopen.2022.36288.
9
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
10
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.

引用本文的文献

1
Don't know much about geography? Decision support for the evaluation of patients with suspected high consequence infectious diseases.对地理知识了解不多?疑似高后果传染病患者评估的决策支持。
Antimicrob Steward Healthc Epidemiol. 2025 Sep 1;5(1):e192. doi: 10.1017/ash.2025.10038. eCollection 2025.
2
TB or not TB? Development and validation of a clinical decision support system to inform airborne isolation requirements in the evaluation of suspected tuberculosis.是结核病还是非结核病?开发并验证一个临床决策支持系统,以在疑似结核病评估中指导空气传播隔离要求。
Infect Control Hosp Epidemiol. 2025 Jan 2;46(2):1-9. doi: 10.1017/ice.2024.214.
3

本文引用的文献

1
Clinical, Laboratory, and Radiologic Characteristics of Patients With Initial False-Negative Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Test Results.初始严重急性呼吸综合征冠状病毒2核酸扩增检测结果为假阴性患者的临床、实验室及影像学特征
Open Forum Infect Dis. 2020 Nov 24;8(1):ofaa559. doi: 10.1093/ofid/ofaa559. eCollection 2021 Jan.
2
Automatic ID Consultation for Inpatients With COVID-19: Point, Counterpoint, and a Single-Center Experience.针对新冠肺炎住院患者的自动身份识别咨询:正方观点、反方观点及单中心经验
Open Forum Infect Dis. 2020 Aug 11;7(10):ofaa318. doi: 10.1093/ofid/ofaa318. eCollection 2020 Oct.
3
Separating the rash from the chaff: novel clinical decision support deployed during the mpox outbreak.
去伪存真:猴痘疫情期间部署的新型临床决策支持工具
Infect Control Hosp Epidemiol. 2024 Aug;45(8):1006-1008. doi: 10.1017/ice.2024.51. Epub 2024 Apr 2.
4
Handheld Lung Ultrasound to Detect COVID-19 Pneumonia in Inpatients: A Prospective Cohort Study.手持式肺部超声检测住院患者的新冠肺炎肺炎:一项前瞻性队列研究。
POCUS J. 2023 Nov 27;8(2):175-183. doi: 10.24908/pocus.v8i2.16484. eCollection 2023.
5
Relative bed allocation for COVID-19 patients, EHR investments, and COVID-19 mortality outcomes.新冠患者床位分配、电子健康记录投资与新冠死亡率结果的关系。
PLoS One. 2023 Oct 26;18(10):e0286210. doi: 10.1371/journal.pone.0286210. eCollection 2023.
6
Development and implementation of a clinical decision support system tool for the evaluation of suspected monkeypox infection.开发和实施一种临床决策支持系统工具,用于评估疑似猴痘感染。
J Am Med Inform Assoc. 2022 Nov 14;29(12):2124-2127. doi: 10.1093/jamia/ocac151.
7
A scoping review of knowledge authoring tools used for developing computerized clinical decision support systems.对用于开发计算机化临床决策支持系统的知识创作工具的范围综述。
JAMIA Open. 2021 Dec 16;4(4):ooab106. doi: 10.1093/jamiaopen/ooab106. eCollection 2021 Oct.
8
Yield of Severe Acute Respiratory Syndrome Coronavirus 2 Lower Respiratory Tract Testing After a Negative Nasopharyngeal Test Among Hospitalized Persons Under Investigation for Coronavirus Disease 2019.2019冠状病毒病疑似住院患者鼻咽检测阴性后严重急性呼吸综合征冠状病毒2下呼吸道检测的阳性率
Open Forum Infect Dis. 2021 May 19;8(6):ofab257. doi: 10.1093/ofid/ofab257. eCollection 2021 Jun.
9
Reducing Morbidity and Mortality Rates from COVID-19, Influenza and Pneumococcal Illness in Nursing Homes and Long-Term Care Facilities by Vaccination and Comprehensive Infection Control Interventions.通过接种疫苗和全面感染控制干预措施降低养老院和长期护理机构中新冠肺炎、流感和肺炎球菌疾病的发病率和死亡率。
Geriatrics (Basel). 2021 May 8;6(2):48. doi: 10.3390/geriatrics6020048.
Delphi, non-RAND modified Delphi, RAND/UCLA appropriateness method and a novel group awareness and consensus methodology for consensus measurement: a systematic literature review.
德尔菲法、非随机化德尔菲法、RAND/UCLA 适宜性方法和一种新的共识测量群体意识和共识方法:系统文献回顾。
Curr Med Res Opin. 2020 Nov;36(11):1873-1887. doi: 10.1080/03007995.2020.1816946. Epub 2020 Sep 15.
4
Outcomes from an infectious disease physician-guided evaluation of hospitalized persons under investigation for coronavirus disease 2019 (COVID-19) at a large US academic medical center.美国一大学附属医院传染病专家对住院疑似 2019 冠状病毒病(COVID-19)患者的评估结果。
Infect Control Hosp Epidemiol. 2021 Mar;42(3):344-347. doi: 10.1017/ice.2020.434. Epub 2020 Aug 24.
5
Clinical Sensitivity of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Tests for Diagnosing Coronavirus Disease 2019.严重急性呼吸综合征冠状病毒2核酸扩增检测对诊断2019冠状病毒病的临床敏感性
Open Forum Infect Dis. 2020 Jul 24;7(8):ofaa315. doi: 10.1093/ofid/ofaa315. eCollection 2020 Aug.
6
Validation of the Corona-Score for rapid identification of SARS-CoV-2 infections in patients seeking emergency department care in the United States.用于快速识别在美国急诊科就诊患者中感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的Corona评分的验证。
Clin Chem Lab Med. 2020 Aug 10;58(12):e311-e313. doi: 10.1515/cclm-2020-1121.
7
Nosocomial outbreak of SARS-CoV-2 infection in a haematological unit - High mortality rate in infected patients with haematologic malignancies.血液科发生的 2019 新型冠状病毒感染医院感染暴发——血液恶性肿瘤感染患者的死亡率高。
J Clin Virol. 2020 Sep;130:104574. doi: 10.1016/j.jcv.2020.104574. Epub 2020 Aug 1.
8
Utility of repeat testing for COVID-19: Laboratory stewardship when the stakes are high.新冠病毒重复检测的效用:高风险下的实验室管理。
Infect Control Hosp Epidemiol. 2021 Mar;42(3):338-340. doi: 10.1017/ice.2020.397. Epub 2020 Aug 3.
9
Nosocomial spread of COVID-19: lessons learned from an audit on a stroke/neurology ward in a UK district general hospital.COVID-19 医院内传播:从英国地区综合医院中风/神经科病房的审计中吸取的经验教训。
Clin Med (Lond). 2020 Sep;20(5):e173-e177. doi: 10.7861/clinmed.2020-0422. Epub 2020 Jul 27.
10
A predictive model and scoring system combining clinical and CT characteristics for the diagnosis of COVID-19.一种结合临床和 CT 特征的 COVID-19 诊断预测模型和评分系统。
Eur Radiol. 2020 Dec;30(12):6797-6807. doi: 10.1007/s00330-020-07022-1. Epub 2020 Jul 1.